EXCLUSIVE: Hoth Therapeutics Targets Faster Drug Discovery With New AI Platform

Benzinga_recent_news03-26

The deployment of OpenClaw represents a move to centralize and optimize research operations. The platform integrates both preclinical and clinical datasets in real time, enabling researchers to access...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2622854208?lang=en_US&edition=fundamental","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/26/AI-Transforms-Healthcare.jpeg?optimize=medium&dpr=2&auto=webp&width=240","is_english":true,"pubTime":"2026-03-26 19:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2622854208","market":"sh","top_or_hot":-1,"title":"EXCLUSIVE: Hoth Therapeutics Targets Faster Drug Discovery With New AI Platform","media":"Benzinga_recent_news","content":"<div>\n<p>The deployment of OpenClaw represents a move to centralize and optimize research operations.\nThe platform integrates both preclinical and clinical datasets in real time, enabling researchers to access...</p>\n\n<a href=\"https://www.benzinga.com/news/health-care/26/03/51477789/exclusive-hoth-therapeutics-targets-faster-drug-discovery-with-new-ai-platform\">Source Link</a>\n\n</div>\n","source":"benzinga_recent_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EXCLUSIVE: Hoth Therapeutics Targets Faster Drug Discovery With New AI Platform</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEXCLUSIVE: Hoth Therapeutics Targets Faster Drug Discovery With New AI Platform\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-26 19:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/health-care/26/03/51477789/exclusive-hoth-therapeutics-targets-faster-drug-discovery-with-new-ai-platform><strong>Benzinga_recent_news</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The deployment of OpenClaw represents a move to centralize and optimize research operations.\nThe platform integrates both preclinical and clinical datasets in real time, enabling researchers to access...</p>\n\n<a href=\"https://www.benzinga.com/news/health-care/26/03/51477789/exclusive-hoth-therapeutics-targets-faster-drug-discovery-with-new-ai-platform\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AGIX","symbol_name":"通用人工智能 ETF-AGIX","start_time":0,"source_url":"https://www.benzinga.com/news/health-care/26/03/51477789/exclusive-hoth-therapeutics-targets-faster-drug-discovery-with-new-ai-platform","article_id":"2622854208","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/26/AI-Transforms-Healthcare.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/26/03/51477789/exclusive-hoth-therapeutics-targets-faster-drug-discovery-with-new-ai-platform","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2622854208","pubTimestamp":1774524660,"columns":[],"sourceInfo":{"source_id":"benzinga_recent_news","name":"Benzinga"},"weMediaInfo":null,"summary":"Hoth Therapeutics launches OpenClaw AI platform to speed drug discovery, improve data integration, and boost development efficiency.","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"AGIX":"通用人工智能 ETF-AGIX","BK4007":"制药","HOTH":"Hoth Therapeutics","AIPO":"Defiance AI and Power Infrastructure ETF","CHAT":"ROUNDHILL GENERATIVE AI & TECHNOLOGY ETF"},"translate_title":"独家：Hoth Therapeutics旨在通过新的人工智能平台加快药物发现速度","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HOTH":1.5,"AIPO":1.5,"CHAT":1.5,"AGIX":1.5},"content_text":"The deployment of OpenClaw represents a move to centralize and optimize research operations.\nThe platform integrates both preclinical and clinical datasets in real time, enabling researchers to access and analyze information more efficiently.\nBy consolidating data streams, the system is designed to enhance execution speed and reduce inefficiencies typically associated with fragmented research workflows.\nOpenClaw is built to process complex biological datasets rapidly, helping identify and prioritize promising drug candidates.\nThis capability is expected to support more informed decision-making while improving the probability of technical success across the company's development programs.\nThe platform's analytical capabilities may also allow the company to streamline timelines, potentially accelerating the progression of therapies through various stages of development.\nThe modular architecture of OpenClaw enables deployment across multiple indications, including dermatology, oncology, and inflammatory diseases. This design allows for standardized workflows while improving reproducibility across research programs.\nBy eliminating data silos, the system supports a more cohesive approach to development, allowing teams to operate with greater consistency and coordination.\n\"We are entering a new phase of execution at Hoth,\" said Robb Knie, CEO. OpenClaw enhances our ability to move faster, make better decisions, and extract more value from our data—positioning us to accelerate development and maximize long-term shareholder value.\"\nIn March, Hoth Therapeutics deployed the OpenAI API to support IND-enabling development of HT-KIT, targeting rare and aggressive KIT-driven cancers.\nThe company integrated an OpenAI-powered API platform into the HT-KIT development workflow to support preclinical data analysis, molecular modeling of KIT-driven pathways, and preparation of regulatory documentation ahead of IND submission.\nHOTH Price Action: Hoth Therapeutics shares were down 0.06% at $0.89 during premarket trading on Thursday, according to Benzinga Pro data.\nImage via Shutterstock\nTo add Benzinga News as your preferred source on Google, click here.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2622854208","isCrawlerRequest":true}